The diarylquinoline TMC207 for multidrug-resistant tuberculosis - Wikidata - wikimedia - TriplyDB

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

http://www.wikidata.org/entity/Q28247333

about

A brief history of the antibiotic era: lessons learned and challenges for the future Culture conversion among HIV co-infected multidrug-resistant tuberculosis patients in Tugela Ferry, South Africa TMC207 for treatment of people with pulmonary tuberculosis Fluoroquinolones for treating tuberculosis (presumed drug-sensitive)TMC207: the first compound of a new class of potent anti-tuberculosis drugs New Antituberculosis Drugs: From Clinical Trial to Programmatic Use New agents for the treatment of drug-resistant Mycobacterium tuberculosis Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review Management of multidrug-resistant TB: novel treatments and their expansion to low resource settings Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?Medical Management of Drug-Resistant Tuberculosis Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment?Antituberculosis therapy for 2012 and beyond Extensively drug-resistant tuberculosis: epidemiology and management Who will develop new antibacterial agents?Role of microparticles in dengue virus infection and its impact on medical intervention strategies Bedaquiline: a review of human pharmacokinetics and drug-drug interactions Rising to the challenge: new therapies for tuberculosis Triazaspirodimethoxybenzoyls as Selective Inhibitors of Mycobacterial Lipoamide Dehydrogenase,Variations of Subunit of the Mycobacterium tuberculosis F1Fo ATP Synthase and a Novel Model for Mechanism of Action of the Tuberculosis Drug TMC207 Piperidinols That Show Anti-Tubercular Activity as Inhibitors of Arylamine N-Acetyltransferase: An Essential Enzyme for Mycobacterial Survival Inside Macrophages Towards a new combination therapy for tuberculosis with next generation benzothiazinones Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations Recent Developments and Future Opportunities in the Treatment of Tuberculosis in Children High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis Probing the interaction of the diarylquinoline TMC207 with its target mycobacterial ATP synthase Sterilizing activity of second-line regimens containing TMC207 in a murine model of tuberculosis Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania.Global financing and long-term technical assistance for multidrug-resistant tuberculosis: scaling up access to treatment Succinate dehydrogenase is the regulator of respiration in Mycobacterium tuberculosis Bibliometric analysis of worldwide publications on multi-, extensively, and totally drug - resistant tuberculosis (2006-2015)New anti-tuberculosis drugs and regimens: 2015 update Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis Pipeline of drugs for related diseases: tuberculosis Establishing Virulence Associated Polyphosphate Kinase 2 as a drug target for Mycobacterium tuberculosis Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars

P2860

Q21131155-C6E1A4FC-D36D-41FE-9B0A-58A7D8B11A19 Q21562122-F9083FA2-8983-47EE-90B7-22178D68BD08 Q24199155-EE2FE6CB-F584-4351-ACD3-7300709833BC Q24202081-6E4C83D0-7AFF-4AB0-84CD-EE16862FA910 Q24632091-6C25E639-2B05-473E-A8B7-4DA0B860A7E1 Q26741138-84AE77FA-36B5-473F-948E-EB5EE2B3D9BC Q26751463-64EAFE58-34A9-4D89-A48C-8056B9A79897 Q26764847-F9BF80F3-90BD-45C2-88E6-0333848A292F Q26765394-FC30AD34-5321-4B01-AD54-BC6705C90E9C Q26771997-0098A16D-E22C-482F-B82A-9288518EADC8 Q26801601-AFE2DC1A-C45C-4387-A602-51EFE61BB609 Q26824413-A0085232-71BA-4772-AFBB-D371F8FE849F Q26829101-7127B1BF-486E-4DA6-8D12-C8DEB2C36B80 Q26830094-89FE0D84-A1B5-4382-A550-C8C4E3A71920 Q26851875-B067EA64-A3AF-4D50-A8F8-940F462F1819 Q26860307-C99CD9C6-5074-4D5B-8A0C-9BC38D6ABDC9 Q26864991-AAAD2628-5417-4FCA-94E5-42450AC84AF0 Q27011672-03EBA613-3634-4CA8-835B-F5C9380E65EB Q27658975-CE88ACB6-A4C6-41DB-93CA-B070EBF44A8B Q27674675-0ADC6D60-97F5-46D5-ACCA-F95D7B7C455F Q27675714-13352467-3ABB-4015-AC85-9DC29CC506BD Q27681604-2B9B6ED2-BD48-455B-B8A9-7EEFB87FA663 Q28072205-32D8B915-C34E-49CF-8F7A-76068AF94799 Q28085210-56731EF7-CD6A-4D12-B292-F5BD879F71A9 Q28391941-EB04FC5C-977F-4536-A329-1BBB350C01EA Q28471626-AEE72BD3-570C-4460-BC03-752EF630875C Q28475461-56CB4CB6-50FB-4C95-9F6B-A8024C1BFE89 Q28476612-989AEFA3-F51F-469F-BA01-BC64DDD905D8 Q28477317-AD5839D0-B3EB-4243-9F3F-B7E0F43DE317 Q28478966-2E9A1F2C-079B-47D9-8678-3D30E8BF58D3 Q28487938-63592579-42EE-4180-8C5C-8DCD346DF2EE Q28487970-001C29AD-36F1-4AC1-B886-B6C9854C9BC2 Q28543392-550BCAE2-4A43-4950-8715-013EC432427C Q28545101-4DE3D233-398D-4DD1-9808-EB4E25D7828B Q28555235-D6E04DD8-8F58-4CE2-9380-4F4785EADFC0 Q28596775-8822C611-4011-45C9-AA56-1523CA90643D Q28659633-084CFEEC-94E3-45C1-B16C-318EB98A8B1E Q28818217-E1782D67-5DF8-430E-9C41-E39DB4182C18 Q28828317-902B8F3D-114A-41C0-AABB-0ACA886AF30D Q28833704-F07AC9E4-0E99-40AF-8AA4-9DC977F672DC

P2860

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

http://www.wikidata.org/entity/Q28247333

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

@ast

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

@en

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

@nl

type

label

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

@ast

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

@en

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

@nl

prefLabel

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

@ast

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

@en

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

@nl

P1433

Q28247333-2ED7B771-4BFA-478B-8A06-1F551107B070

P1476

Q28247333-E470D6BC-0BC8-4F01-865B-68553F618A8C

P2093

Q28247333-185FF1CF-BD0F-487B-AC48-CC8D002DA5C9

Q28247333-29B52247-83A0-4C85-87D7-27FA8EF51452

Q28247333-2AD120E6-5067-49D0-8498-C6D12DC3D86B

Q28247333-3BAF6025-72DE-44B9-9C0B-1317F16E640F

Q28247333-410B67DD-3A05-4B2A-B6DF-D2DD338FB9EA

Q28247333-4478E0AD-011B-471D-912D-7743E0CE9D9F

Q28247333-4FC46E22-D1B6-4EBA-9355-7773DFA84603

Q28247333-54F29BC3-EA57-41A2-842E-2B9762822ED7

Q28247333-6C638A21-8345-45FE-9D98-4D1FF847B28E

Q28247333-8D7735C9-D50B-4DDD-9A6B-FDC832646B61

P304

Q28247333-117FD283-F668-4176-B78A-2739868CA977

P31

Q28247333-95EB179B-CBE0-400E-A008-AF667B7DE5DB

P3181

Q28247333-DAF8745C-65CF-45E7-AAD8-6FC47D12A76A

P356

Q28247333-1927DD2D-CA1F-4AF4-95F9-D90DDEBF2B9E

P407

Q28247333-CCF63133-815C-424B-ACAF-D550719A2918

P433

Q28247333-8B2C74CF-E248-465F-AC6F-9D7A450D1B67

P478

Q28247333-4A8C94E9-85D5-4127-B50D-18A42AF3214E

P50

Q28247333-48655203-F347-45E5-B781-2BEB75D5B14B

Q28247333-CDC74B47-D4D8-47D2-9935-25CD55A753D9

P577

Q28247333-4E5CF19F-935A-429D-97BF-9B5DDE8569C3

P698

Q28247333-42EE176A-872A-471B-8535-951A8B4CFD18

P921

Q28247333-32B3CA21-CE53-4F1F-B53D-B42B558E78AC

Q28247333-FB332713-B57D-4F0A-BD91-A84961BC0C72

P3181

P356

P1433

The New England Journal of Medicine

P1476

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

@en

P2093

Amour Venter

http://www.w3.org/2001/XMLSchema#string

Andreas H Diacon

http://www.w3.org/2001/XMLSchema#string

Christoffel Pistorius

http://www.w3.org/2001/XMLSchema#string

David F Mc Neeley

http://www.w3.org/2001/XMLSchema#string

Jenny Allen

http://www.w3.org/2001/XMLSchema#string

Johan Verbeeck

http://www.w3.org/2001/XMLSchema#string

Juan Carlos Palomino

http://www.w3.org/2001/XMLSchema#string

Karel de Beule

http://www.w3.org/2001/XMLSchema#string

Koen Andries

http://www.w3.org/2001/XMLSchema#string

Liesl Page-Shipp

http://www.w3.org/2001/XMLSchema#string

P304

2397-2405

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

506028

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA0808427

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

360

http://www.w3.org/2001/XMLSchema#string

P50

Alexander S Pym

Gavin J Churchyard

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19494215

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

multiple drug resistance